Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Metoclopramide hydrochloride anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 78 FDA Orange Book, 9 Europe, 10 Canada, 4 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 15 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 16 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 41 Direct Compression, 34 Disintegrants & Superdisintegrants, 30 Taste Masking, 28 Granulation, 24 Thickeners and Stabilizers, 21 Chewable & Orodispersible Aids, 20 Parenteral, 19 Film Formers & Plasticizers, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 11 Coating Systems & Additives, 11 Solubilizers, 8 Empty Capsules, 7 Controlled & Modified Release, 6 Topical, 5 Emulsifying Agents, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

12 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents

7 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Amsa	Italy	AMSA S. p. A.	221MF10057	METOCLOPRAMIDE DIHYDROCHLORIDE	2009-03-19	2024-12-18	VIALE DEL GHISALLO, 20 20151 MILAN ITALY

Metoclopramide Hydrochloride Anhydrous

Metoclopramide hydrochloride anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

10 USDMF

4 CEP/COS

1 JDMF

3 EU WC

9 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers

78 FDA Orange Book

9 Europe

10 Canada

4 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

5 Evonik

5 Rochem International Inc

18 SPI Pharma

6 DKSH

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

17 BASF

1 CD Formulation

2 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

15 Kerry

2 Keval Exports

3 Lonza Capsugel

16 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qualicaps

28 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

1 Ulanqab Kema New Material

2 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders

41 Direct Compression

34 Disintegrants & Superdisintegrants

30 Taste Masking

28 Granulation

INJECTABLE;INJECTION - EQ 5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons